spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Synthetic Biology Congress

Oxford Global Events - Synthetic Biology

8-9 November 2018
London, UK

Oxford Global is proud to present its Synthetic Biology Congress taking place on 8-9 November 2018 in London. As part of our Genomics and Synthetic Biology UK series, our congress will bring together Over 600 delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies.

Our Synthetic Biology Congress will feature over 20 presentations and case studies demonstrating the latest synthetic biology tools and their therapeutic applications.

World renowned experts will give over 20 presentations across 2 interactive streams, including;

·         Synthetic Biology – Tool Development

·         Synthetic Biology – Applications 

View the Agenda here>> https://bit.ly/2Mton5I

This event will be co-located with our highly established 10th Annual Next Generation Sequencing and Clinical Diagnostics Congress, 6th Annual Single Cell Analysis Congress and the 4th Annual Genome Editing Congress 

For further information, prices & group discounts please contact d.dalby@oxfordglobal.co.uk

phone +44 (0)1865 248455
email d.dalby@oxfordglobal.co.uk
web https://bit.ly/2MtRRQY
email London
 
Print this page
Send to a friend
   
spacer
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>


White Papers

Managing GxP Environmental Systems to Ensure Data Integrity

Vaisala Ltd


More info >>


News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement